Virtual – July 20 at 1 p.m. ET / 10 a.m. PT

Once again Congress is barreling towards drug pricing reform. STAT will sit down with key decision makers to talk about the latest developments from Capitol Hill and the White House.



Brent Dover, CEO, Kalderos (sponsor speaker)

Part 1: A Top Senator’s View

Sen. Ron Wyden (D-Ore.), Chairman of the Senate Finance Committee
Rachel Cohrs, Washington correspondent, STAT (moderator)

Part 2: Listening to the Experts

Rena Conti, Ph.D., associate professor, Department of Markets, Public Policy and Law, Questrom School of Business, Boston University
Stacie B. Dusetzina, Ph.D., associate professor of health policy, Ingram associate professor of cancer research, Vanderbilt University School of Medicine
Richard G. Frank, Ph.D., director of the USC-Brookings Schaeffer Initiative on Health Policy; fellow in economic studies; Margaret T. Morris professor of health economics, emeritus, department of health care policy, Harvard Medical School
Rachel Cohrs, Washington correspondent, STAT (moderator)


Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.